Trademark Overview
On Friday, March 27, 2015, a trademark application was filed for VARONEL with the United States Patent and Trademark Office. The USPTO has given the VARONEL trademark a serial number of 86578327. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, January 15, 2016. This trademark is owned by Glaxo Group Limited. The VARONEL trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines